Pigott John H, Ishihara Akikazu, Wellman Maxey L, Russell Duncan S, Bertone Alicia L
Comparative Orthopedics Research Laboratory, Departments of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, United States.
Vet Immunol Immunopathol. 2013 Nov 15;156(1-2):99-106. doi: 10.1016/j.vetimm.2013.09.003. Epub 2013 Sep 18.
Mesenchymal stem cells have demonstrated immunomodulatory capabilities as well as modest efficacy in animal models of joint injury, warranting further study as a potential treatment of joint disease. The goal of the study was to investigate the blood and synovial immune and histologic response to intra-articular injection of autologous, allogeneic, and xenogeneic bone marrow-derived mesenchymal stem cells (MSC) in horses. The study group consisted of 6 five-year-old Thoroughbred mares that had been injected previously with 15 million, genetically modified autologous, allogeneic, or xenogeneic MSC into the fetlock joints. One group of autologous cells was genetically modified to permit MSC biolocalization in the synovium. To assess response to the injection, synovial biopsies were obtained via arthroscopy 60 days after MSC injection for gross, histologic and molecular analyses. Peripheral blood mononuclear cells were isolated from each horse 120 days after MSC injection and co-cultured with a monolayer of each MSC group to permit quantification of activated CD4+ lymphocytes and cytokine release (ELISA) upon re-exposure to MSC. Arthroscopic examination revealed normal synovium with no grossly detrimental effect to the synovium or cartilage. Intra-articular MSC produced a persistent mononuclear infiltrate for at least 60 days, mostly perivascular, identified as CD3+ lymphocytes. An immune response (significant increase in CD4+ lymphocytes) was detected upon re-exposure to xenogeneic but not to allogeneic or autologous MSC. An inflammatory cytokine release from peripheral blood mononuclear cell/MSC co-cultures was present in all MSC groups but was significantly greater in the xenogeneic group. In conclusion, intra-articular injection of MSC, regardless of cell origin, incited a persistent mononuclear synovitis demonstrating a sustained biologic influence of these cells. Allogeneic cells did not elicit a detectable immune response upon re-exposure using our methods.
间充质干细胞在关节损伤动物模型中已显示出免疫调节能力以及一定疗效,有必要作为关节疾病的潜在治疗方法进一步研究。本研究的目的是调查马关节腔内注射自体、异体和异种骨髓来源的间充质干细胞(MSC)后血液和滑膜的免疫及组织学反应。研究组由6匹5岁的纯种母马组成,这些母马先前已向球节关节内注射了1500万个经基因改造的自体、异体或异种MSC。一组自体细胞经过基因改造,以使MSC能在滑膜中生物定位。为评估对注射的反应,在MSC注射后60天通过关节镜检查获取滑膜活检样本,进行大体、组织学和分子分析。在MSC注射后120天从每匹马中分离出外周血单个核细胞,并与每个MSC组的单层细胞共培养,以便在再次接触MSC时定量活化的CD4+淋巴细胞和细胞因子释放(酶联免疫吸附测定)。关节镜检查显示滑膜正常,对滑膜或软骨无明显有害影响。关节内注射MSC产生了至少持续60天的单核细胞浸润,主要是血管周围浸润,鉴定为CD3+淋巴细胞。再次接触异种MSC而非同种异体或自体MSC时检测到免疫反应(CD4+淋巴细胞显著增加)。所有MSC组外周血单个核细胞/MSC共培养物中均存在炎性细胞因子释放,但异种组中释放量显著更高。总之,关节腔内注射MSC,无论细胞来源如何,都会引发持续的单核细胞性滑膜炎,表明这些细胞具有持续的生物学影响。使用我们的方法,再次接触同种异体细胞时未引发可检测到的免疫反应。